Origin Therapeutics Holdings, Inc. (SPLY) Cash flow

3 Followers

Origin Therapeutics Holdings, Inc. Cash Flow

TSE:SPLY's free cash flow for Q3 2024 was $―. For the 2024 fiscal year, TSE:SPLY's free cash flow was decreased by $― and operating cash flow was $-497.23K. See a summary of the company’s cash flow.

Cash Flow	Sep 23	Sep 22	Sep 21
Operating Cash Flow	$ -924.14K	$ -983.68K	$ -311.51K
Investing Cash Flow	$ ―	$ ―	$ ―
Financing Cash Flow	$ ―	$ ―	$ ―
End Cash Position	$ ―	$ ―	$ ―
Free Cash Flow	$ ―	$ ―	$ -311.51K

Currency in USD